The city of Miami claims pharmaceutical companies and drug distributors deceived opioid users with aggressive marketing tactics into believing their products were safe but in reality contributed to the opioid epidemic affecting millions of Americans.

Lawyers representing the city filed a lawsuit Monday under Florida’s Deceptive and Unfair Trade Practices Act against a host of pharmaceutical companies and distributors led by Purdue Pharma LP, maker of the widely prescribed OxyContin, as well as Janssen, Ortho-McNeil, AmerisourceBergen and Walgreens.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]